Handelsavisen
prelaunch
Companies ›Consumer Cyclicals ›PRAX.NS
PR
PRAX.NS — NSE (India) Home Furnishings Retailers

Prax.Ns

$7,70
Open in Charts → Attach watcher ⌖
— —
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
—
P/E
—
EV / Rev
—
Div yield
—
Op margin
-13,8 %
ROE
56,9 %
Net margin
-29,4 %
Debt / equity
-4,12
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
$307,75
Open
—
Next earnings
—
Ex-dividend
—
TR 1Y
—
About

PRAX.NS operates in the home furnishings retail sector, offering products and services to consumers in the retail space.

Business. PRAX.NS operates in the home furnishings retail sector, offering products and services to consumers in the retail space.

Classification92 %
SectorConsumer Cyclicals
Business sectorRetailers
IndustryHome Furnishings Retailers
ActivityRetailers
Generated · model-assisted
Sell-side consensus
BUY19 analysts
17 buy1 hold1 sell
Avg 12m price target603,89

Analyst recommendations

19 analysts · consensus Buy
Buy17
Hold1
Sell1
12-month price target
603,89
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
—
not yet scored
Valuation
—
valuation pending
Analysts→
Buy
19 analysts · indicative
Ownership→
T. Rowe Price Investment Management, Inc.
largest disclosed fund holder
Profitability→
56,9 %
return on equity
Quality
—
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning PRAX.

    • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary · THIS SECTOR+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to PRAX.NS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    PRAX.NS operates in the home furnishings retail sector, offering products and services to consumers in the retail space.

    Classification92 %
    SectorConsumer Cyclicals
    Business sectorRetailers
    IndustryHome Furnishings Retailers
    ActivityRetailers
    AI synthesis
    GENERATED

    The company's capital structure is heavily leveraged, with total liabilities of INR 37.49 billion and total equity of INR -614.87 million, resulting in a debt-to-equity ratio of -4.12. Liquidity is constrained, as evidenced by a current ratio of 0.65 and negative free cash flow of INR -88.56 million. The negative net income of INR -349.79 million and operating loss of INR -164.28 million indicate significant financial distress.

    Profitability metrics are severely underperforming relative to industry norms. The company's return on assets of -11.16% and return on equity of 56.89% are inconsistent with typical performance in the home furnishings retail sector, where positive returns are expected. Gross profit of INR 404.48 million on revenue of INR 11.90 billion suggests a gross margin of 34.0%, which is high for the sector but insufficient to offset operating and net losses.

    Geographic and segment exposure is not disclosed in the available data, but the company's revenue concentration is implied to be within the home furnishings retail segment. The lack of segment-specific data limits the ability to assess diversification or concentration risk.

    Growth trajectory is negative, with the company reporting declining operating and net income. The financial snapshot does not provide historical revenue data to quantify the rate of decline, but the current operating cash flow of INR -274.88 million indicates ongoing operational challenges.

    Risk factors include liquidity constraints and a negative net income, which could lead to further debt accumulation or equity dilution. The risk assessment indicates a medium liquidity risk and low dilution risk, but the negative net cash position after subtracting total debt is a key flag.

    Recent events, including filings and transcripts, are not detailed in the available data. The company's financial performance and liquidity position suggest a need for close monitoring of future disclosures and strategic actions.

    Key takeaways
    • PRAX.NS is experiencing significant financial distress, with negative net income and operating losses.
    • The company's capital structure is highly leveraged, with a debt-to-equity ratio of -4.12.
    • Profitability metrics are underperforming, with a return on assets of -11.16%.
    • Liquidity is constrained, as indicated by a current ratio of 0.65 and negative free cash flow.
    • The company's financial position suggests a need for strategic interventions to address liquidity and profitability issues.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $7,70
    Market cap
    —
    Enterprise valueⓘ
    —
    P/Eⓘ
    —
    Non-GAAP P/Eⓘ
    —
    EV / Revenueⓘ
    —
    EV / Op incomeⓘ
    —
    EV / OCFⓘ
    —
    P / Bⓘ
    —
    P / Tangible bookⓘ
    —
    Tangible book
    -$614.9M
    Net cashⓘ
    -$2.52B
    Current ratioⓘ
    0.7
    Debt / equityⓘ
    -4.1
    ROAⓘ
    -11.2%
    ROEⓘ
    56.9%
    Cash conversionⓘ
    79.0%
    CapEx / revenueⓘ
    -1.1%
    SBC / revenueⓘ
    —
    Dilution ratioⓘ
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    Business relationships4 disclosed relationships · 2 types · extracted from filings & disclosures
    Partners1
    Ionis Pharmaceuticals IncIONS.OPartner95%Source ↗
    Subsidiaries3
    EX21:32d3153dcc3eEX21:32d3153dcc3eSubsidiarie97%
    EX21:7efb3ad131c5EX21:7efb3ad131c5Subsidiarie97%
    EX21:f9f15f88ae6eEX21:f9f15f88ae6eSubsidiarie97%

    Supply chain

    Vendors → PRAX ↔ Partners → Customers · click any node to drill
    VENDORSPARTNERSCUSTOMERSPRAXPRAXPrax.Ns4 entitiesIonis Pharmaceuticals UnclassifiedUS
    1 mention in 10-K0 from corporate websites0 from news dispatches
    Updated 2026-06-24

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 33 %
    EPS
    Consensus EPS
    -15,16
    Predicted surprise
    -0,02
    Beat probability
    33 %
    Analysts
    19
    Other metrics
    Revenue
    —
    no estimate
    Segment revenue
    —
    no estimate
    Margin
    —
    no estimate
    Segment margin
    —
    no estimate
    as of 2026-08-02 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Corporate eventM&A horizon
    M&A probabilityconf 3 %
    Probability
    3 %
    Base rate
    3 %
    Band
    —
    180-day horizon · target 2027-01-21 · 1,0× base rate
    No acquirer candidates identified by the signal model.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$162,00
    Mean$603,89
    Median$550,00
    High$1 201,00
    Spot$7,70
    +7742.8 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-13,8 %Below median
    Net Margin-29,4 %Bottom quartile
    ROE56,9 %Best in class
    Capex / Rev-1,1 %Above median
    D/E-4,12Best in class
    Cash Conv0,79Below median

    Corporate actions / M&A

    M&A probabilityconf —
    Probability
    3 %
    Base rate
    3 %
    Band
    Low
    180-day horizon · target 2027-01-21 · 1,0× base rate
    No acquirer candidates identified by the signal model.
    Corporate actionsNo corporate-action source connected yet — splits, dividends and buyback events are not tracked for this company. Honest-dim (no data fabricated).

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net acquired 43 882 sh2 exercises · 15 grants13 insiders
    • DeSimone JillDirector · Stock Option (Right to Buy) → Common StockDisposed 8 566 @ $44,25exercise · 2026-06-24
    • DeSimone JillDirector · Stock Option (Right to Buy) → Common StockDisposed 3 034 @ $147,30exercise · 2026-06-24
    • KINDLER JEFFREY BDirector · Stock Option (Right to Buy) → Common StockAcquired 648 @ $240,66grant · 2026-06-10
    • Norden GregoryDirector · Stock Option (Right to Buy) → Common StockAcquired 648 @ $240,66grant · 2026-06-10
    • DeSimone JillDirector · Stock Option (Right to Buy) → Common StockAcquired 648 @ $240,66grant · 2026-06-10
    • YOUNG WILLIAM DDirector · Stock Option (Right to Buy) → Common StockAcquired 648 @ $240,66grant · 2026-06-10
    • Chodakewitz JeffreyDirector · Stock Option (Right to Buy) → Common StockAcquired 648 @ $240,66grant · 2026-06-10
    • Arbuckle Stuart ADirector · Stock Option (Right to Buy) → Common StockAcquired 648 @ $240,66grant · 2026-06-10
    • Cudkowicz Merit EsterDirector · Stock Option (Right to Buy) → Common StockAcquired 648 @ $240,66grant · 2026-06-10
    • MITCHELL DEAN JDirector · Stock Option (Right to Buy) → Common StockAcquired 648 @ $240,66grant · 2026-06-10
    • Arbuckle Stuart ADirector · Stock Option (Right to Buy) → Common StockAcquired 224 @ $319,57grant · 2026-02-06
    • KINDLER JEFFREY BDirector · Stock Option (Right to Buy) → Common StockAcquired 224 @ $319,57grant · 2026-02-06
    • Kelly Timothy EdwinChief Financial Officer · Stock Option (Right to Buy) → Common StockAcquired 7 040 @ $294,38grant · 2026-01-08
    • Nemiroff AlexGeneral Counsel and Secretary · Stock Option (Right to Buy) → Common StockAcquired 5 500 @ $294,38grant · 2026-01-08
    • Mastrocola LaurenPrincipal Accounting Officer · Stock Option (Right to Buy) → Common StockAcquired 7 500 @ $294,38grant · 2026-01-08
    • Souza MarcioDirector, Chief Executive Officer · Stock Option (Right to Buy) → Common StockAcquired 22 110 @ $294,38grant · 2026-01-08
    • Sniecinski MeganChief Operating Officer · Stock Option (Right to Buy) → Common StockAcquired 7 700 @ $294,38grant · 2026-01-08

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • PRAX.NS Market data — financials · 2026-05-29

    Ownership & reference

    Top holders

    • T. Rowe Price Investment Management, Inc.Investment Managers · as of 2026-03-310,04 %$0M
    • FMR LLCInstitutional Investor · as of 2026-03-310,04 %$696M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,03 %$229M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,02 %$0M
    • Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,02 %$89M
    • American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,02 %$41M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,02 %$269M
    • JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,01 %$27M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,01 %$210M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,01 %$69M
    • Wellington Management Company, LLPInvestment Managers · as of 2026-03-310,01 %$56M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,01 %$285M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,01 %$73M
    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,01 %$19M
    • First Trust Advisors L.P.Investment Managers · as of 2026-03-310,01 %$11M
    • Nuveen LLCInvestment Managers · as of 2024-12-310,01 %$24M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,01 %$431M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,01 %$35M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,01 %$28M
    • Invesco QQQ TrustFunds · as of 2026-03-310,00 %$20M
    • Victory Capital Management Inc.Investment Managers · as of 2026-03-310,00 %$5M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,00 %$8M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,00 %$10M
    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,00 %$10M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,00 %$54M
    • MASSACHUSETTS FINANCIAL SERVICES CO /MA/Institutional Investor · as of 2026-03-310,00 %$2M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$4M
    • Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,00 %$2M
    • LPL Financial LLCInvestment Managers · as of 2026-03-310,00 %$1M
    • Principal Global Investors (Equity)Investment Managers · as of 2026-03-310,00 %$0M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,00 %$0M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M

    Insider activity

    Net selling0 buys · 12 sellsnet -$3,6M13 insiders · last 365d
    • Souza MarcioDirector, Chief Executive Officer · Common StockOther 2 600 · 2026-07-08
    • Souza MarcioDirector, Chief Executive Officer · Common StockOther 20 521 · 2026-07-08
    • DeSimone JillDirector · Common StockOther 3 034 @ $147,30$447K · 2026-06-24
    • DeSimone JillDirector · Common StockSold 837 @ $315,70$264K · 2026-06-24
    • DeSimone JillDirector · Common StockSold 1 279 @ $314,90$403K · 2026-06-24
    • DeSimone JillDirector · Common StockSold 504 @ $313,66$158K · 2026-06-24
    • DeSimone JillDirector · Common StockSold 1 004 @ $312,83$314K · 2026-06-24
    • DeSimone JillDirector · Common StockSold 2 854 @ $311,91$890K · 2026-06-24
    • DeSimone JillDirector · Common StockSold 1 750 @ $310,89$544K · 2026-06-24
    • DeSimone JillDirector · Common StockSold 999 @ $309,38$309K · 2026-06-24
    • DeSimone JillDirector · Common StockSold 1 240 @ $308,24$382K · 2026-06-24
    • DeSimone JillDirector · Common StockSold 683 @ $306,77$210K · 2026-06-24
    • DeSimone JillDirector · Common StockSold 10 @ $301,44$3K · 2026-06-24
    • DeSimone JillDirector · Common StockSold 320 @ $305,31$98K · 2026-06-24
    • DeSimone JillDirector · Common StockSold 120 @ $303,13$36K · 2026-06-24
    • DeSimone JillDirector · Common StockOther 8 566 @ $44,25$379K · 2026-06-24
    • Cudkowicz Merit EsterDirector · Common StockOther 1 371 · 2026-06-10
    • MITCHELL DEAN JDirector · Common StockOther 1 371 · 2026-06-10
    • Norden GregoryDirector · Common StockOther 1 371 · 2026-06-10
    • KINDLER JEFFREY BDirector · Common StockOther 1 371 · 2026-06-10
    • Arbuckle Stuart ADirector · Common StockOther 1 371 · 2026-06-10
    • Chodakewitz JeffreyDirector · Common StockOther 1 371 · 2026-06-10
    • YOUNG WILLIAM DDirector · Common StockOther 1 371 · 2026-06-10
    • DeSimone JillDirector · Common StockOther 1 371 · 2026-06-10
    • Mastrocola LaurenPrincipal Accounting Officer · Common StockOther 127 @ $167,94$21K · 2026-05-14

    Short positioning

    3.8Mshares short-5.6% vs prior
    9.21days to cover
    73.4%short of daily vol
    8.3Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    PRAX.NSCanonical
    NSE (India) · USD

    Intel & risk

    PredictorBeat prob33 %Surprise-0,02M&A prob3 %Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    PRAXIONS.OEX21:32dEX21:7efEX21:f9fHome Furnishin
    This companySectorPartnersSubsidiaries

    Evidence & claims

    From filings & derived data
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 65.9%Derived (calculated)
    • Return on equity (FY 2025-12-31): -34.5%Derived (calculated)
    • Return on assets (FY 2025-12-31): -32.3%Derived (calculated)
    • Current ratio (FY 2025-12-31): 10.22xDerived (calculated)
    • Debt-to-equity (FY 2025-12-31): 0.07xDerived (calculated)
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -32.0%Derived (calculated)
    • EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -32.0%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): -65.6%Derived (calculated)
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -89.0%Derived (calculated)
    • Operating income (YoY) (2025-12-31 vs 2024-12-31): -63.0%Derived (calculated)
    • R&D expense (YoY) (2025-12-31 vs 2024-12-31): 75.3%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 97.1%Derived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): 94.1%Derived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 58.7%Derived (calculated)
    • Revenue (YoY) (2025-12-31 vs 2024-12-31): -100.0%Derived (calculated)
    • Current liabilities (annual): USD 59.77MSEC XBRL filing
    • Current assets (annual): USD 610.91MSEC XBRL filing
    • Shares outstanding (annual): 25.2MSEC XBRL filing
    • Operating cash flow (annual): USD -249.07MSEC XBRL filing
    • Total operating expenses (annual): USD 326.2MSEC XBRL filing
    • Net income (annual): USD -303MSEC XBRL filing
    • EPS (basic) (annual): USD-PER-SHARES -13SEC XBRL filing
    • Cash & equivalents (annual): USD 357.33MSEC XBRL filing
    • Revenue (annual): USD 0SEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-08-03 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
    2026-08-03EVENTQ2 2026 earnings (expected) estimated date
    2026-07-08INSIDERSouza Marcio transacted 2.6k sh — Director, Chief Executive Officer
    2026-07-08INSIDERSouza Marcio transacted 20.5k sh — Director, Chief Executive Officer
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: ma_probability (180d)
    2026-06-26 03:13 UTCHOLDERInstitutional holding changed
    2026-06-26 03:13 UTCHOLDER1 institutional position change flagged (1 major)
    2026-06-24 00:00 UTCINSIDER32 insider transactions — 2026-06 · net sell $2.8M 10 derivative
    2026-06-24INSIDERDeSimone Jill transacted 3.0k sh — Director ~$447k
    2026-06-24INSIDERDeSimone Jill sold 837 sh — Director ~$264k
    2026-06-24INSIDERDeSimone Jill sold 1.3k sh — Director ~$403k
    2026-06-24INSIDERDeSimone Jill sold 504 sh — Director ~$158k
    2026-06-24INSIDERDeSimone Jill sold 1.0k sh — Director ~$314k
    2026-06-24INSIDERDeSimone Jill sold 2.9k sh — Director ~$890k
    2026-06-24INSIDERDeSimone Jill sold 1.8k sh — Director ~$544k
    2026-06-24INSIDERDeSimone Jill sold 999 sh — Director ~$309k
    2026-06-24INSIDERDeSimone Jill sold 1.2k sh — Director ~$382k
    2026-06-24INSIDERDeSimone Jill sold 683 sh — Director ~$210k
    2026-06-24INSIDERDeSimone Jill sold 10 sh — Director ~$3k
    2026-06-24INSIDERDeSimone Jill sold 320 sh — Director ~$98k
    2026-06-24INSIDERDeSimone Jill sold 120 sh — Director ~$36k
    2026-06-24INSIDERDeSimone Jill transacted 8.6k sh — Director ~$379k
    2026-06-24INSIDERDeSimone Jill disposed of 8.6k sh Stock Option (Right to Buy) — Director
    2026-06-24INSIDERDeSimone Jill disposed of 3.0k sh Stock Option (Right to Buy) — Director
    2026-06-21 02:57 UTCHOLDERInstitutional holding changed
    2026-06-21 02:57 UTCHOLDER1 institutional position change flagged (1 major)
    2026-06-12FILING8-K filing →
    2026-06-10INSIDERCudkowicz Merit Ester transacted 1.4k sh — Director
    2026-06-10INSIDERMITCHELL DEAN J transacted 1.4k sh — Director
    2026-06-10INSIDERNorden Gregory transacted 1.4k sh — Director
    2026-06-10INSIDERKINDLER JEFFREY B transacted 1.4k sh — Director
    2026-06-10INSIDERArbuckle Stuart A transacted 1.4k sh — Director
    2026-06-10INSIDERChodakewitz Jeffrey transacted 1.4k sh — Director
    2026-06-10INSIDERYOUNG WILLIAM D transacted 1.4k sh — Director
    2026-06-10INSIDERDeSimone Jill transacted 1.4k sh — Director
    2026-06-10INSIDERKINDLER JEFFREY B acquired 648 sh Stock Option (Right to Buy) — Director
    2026-06-10INSIDERChodakewitz Jeffrey acquired 648 sh Stock Option (Right to Buy) — Director
    2026-06-10INSIDERMITCHELL DEAN J acquired 648 sh Stock Option (Right to Buy) — Director
    2026-06-10INSIDERCudkowicz Merit Ester acquired 648 sh Stock Option (Right to Buy) — Director
    2026-06-10INSIDERDeSimone Jill acquired 648 sh Stock Option (Right to Buy) — Director
    Showing the 40 most recent of 63 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage